Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk …
2 days ago · News provided by Variant Bio, Inc. Jan 07, 2025, 07:03 ET . Share this article ... Novo Nordisk will pay Variant Bio an upfront payment and additional near-term R&D funding totaling up to $50 ...
Variant Bio and Novo Nordisk to identify targets for metabolic …
2 days ago · As part of the agreement, Novo Nordisk will provide Variant Bio with an upfront payment and additional near-term research and development (R&D) funding that could reach up to $50m.
Drug Company to Share Revenues With Indigenous People Who …
2 days ago · On Tuesday, his company, Variant Bio, based in Seattle, announced a $50 million collaboration with the drugmaker Novo Nordisk to develop drugs for metabolic disorders, including diabetes and ...
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk …
2 days ago · The multi-year target discovery collaboration announced today signals a new chapter of growth for Variant Bio. The strategic partnership with Novo Nordisk demonstrates the value of Variant Bio’s potential to enable the development of novel therapeutics based on results from its innovative genomic studies. About Variant Bio. Variant Bio is ...
Novo inks $50M metabolic disease pact with genomics biotech
2 days ago · Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk …
1 day ago · The strategic partnership with Novo Nordisk demonstrates the value of Variant Bio’s potential to enable the development of novel therapeutics based on results from its innovative genomic studies. About Variant Bio Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits.
Seattle startup lands deal with Novo Nordisk to study obesity
2 days ago · Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M by Lisa Stiffler on January 7, 2025 at 10:07 am January 7, 2025 at 10:10 am Share Tweet Share Reddit Email
Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two
1 day ago · Under the terms of the agreement, Novo Nordisk said it would pay Variant Bio an upfront payment and additional near-term R&D funding totaling up to $50 million, plus potential option and milestone ...
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk …
2 days ago · Variant Bio announced a multi-year research collaboration with Novo Nordisk to discover novel targets for the treatment of metabolic disease. The partnership between Novo Nordisk and Variant Bio is aimed at identifying and validating multiple novel targets with sufficient human genetic evidence to initiate human-centric drug discovery programs.
Variant Bio Announces Multi-Year Research Partnership with Novo Nordisk …
2 days ago · Variant Bio, a genomics-driven drug discovery company, today announced a multi-year research collaboration with Novo Nordisk to discover novel targets for the treatment of metabolic disease.
- Some results have been removed